Menu
RICOVR’s testing platform leverages the first truly portable nanoparticle detection technology, allowing for fast, non- invasive specimen collection and analytics. With the collaboration of industry experts, the company’s platform is versatile and already expanding into new testing diagnostics including , additional drug panels, and critical disease testing.
RICOVR is driven by the belief that a more accurate and cost-effective solution should be available for employers, law enforcement, healthcare systems and others relying on fast and reliable access to data.
RICOVR team includes experts across medical device design and manufacturing, leadership, sales, medicine, technology, and scientific research to deliver on your needs today and tomorrow.
